Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this Phase III study is to evaluate the efficacy and safety of 3APS compared
to placebo (inactive substance pill) in patients with mild to moderate Alzheimer's disease.